AKT1 and rheumatoid arthritis: Meanwhile, Liu et al. suggested that eriodictyol may be a potential treatment for rheumatoid arthritis due to its ability to inhibit inflammatory responses and rescue cell survival in RA-FLS cells by the activating the AKT/forkhead box protein O1 signaling pathway [87].